Skip to content

GLP-1 claim guide

GLP-1 and satiety supplements: what the label can actually prove

GLP-1 language is spreading fast across food and supplement marketing. That does not make a capsule a medication, and it does not make a satiety claim proven.

Last reviewed: 2026-06-03Focus: GLP-1 marketing, satiety, fiber, berberine, medication boundaries
For research and educational purposes only. Not medical advice.

The quick read

The short answer

Treat GLP-1 and satiety supplement claims as label claims, not medical claims. The useful question is what ingredient, dose, fiber type, serving size, and evidence the brand shows. FTC health products compliance guidance FDA supplement claim substantiation guidance

This page does not tell GLP-1 medication users what to take, combine, start, stop, or use for side effects. Ask your prescriber or pharmacist about medication timing, digestion, or supplement changes. DailyMed Wegovy prescribing information FDA Zepbound prescribing information

Satiety is not a free pass

A satiety claim should be product-specific. A fiber study, berberine discussion, or metabolism headline does not automatically validate a finished supplement at its actual dose. FDA supplement claim substantiation guidance FTC health products compliance guidance

The red flag is medication-shaped language without medication-level evidence. A supplement that borrows GLP-1 heat should be more transparent, not less. FDA 101 dietary supplements FDA concerns with unapproved GLP-1 drugs

The NutriScore read

A strong formula shows fiber grams, fiber source, protein grams if present, sugar alcohols, stimulant ingredients, and individual doses for any active blend. FDA dietary fiber label guide FDA dietary supplement labeling guide

If a front label says GLP-1 but the back label hides the numbers, the claim is doing more work than the formula. FTC health products compliance guidance

What to check on the label

Fiber math

Find grams per serving, fiber type, and percent Daily Value.

Medication boundary

Reject any supplement that acts like a prescriber for GLP-1 side effects or timing.

Evidence fit

Ask whether the evidence matches the exact ingredient, amount, format, and claim.

Related NutriScore pages

Sources

  1. AP report on GLP-1-friendly labels: https://apnews.com/article/5bb5dfaae3778b1968c1793326e8ba73
  2. FDA concerns with unapproved GLP-1 drugs: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  3. FDA 101 dietary supplements: https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements
  4. FTC health products compliance guidance: https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  5. FDA supplement claim substantiation guidance: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-substantiation-dietary-supplement-claims-made-under-section-403r-6-federal-food
  6. FDA changes to the Nutrition Facts label: https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/changes-nutrition-facts-label
  7. FDA dietary fiber label guide: https://www.accessdata.fda.gov/scripts/InteractiveNutritionFactsLabel/assets/InteractiveNFL_DietaryFiber_October2021.pdf
  8. FDA dietary supplement labeling guide: https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-iv-nutrition-labeling
  9. DailyMed Wegovy prescribing information: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  10. FDA Zepbound prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf

Corrections: send corrections or updated label/source evidence to support@nutriscore.fit.

Keep reading